IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...

Page created by Helen Freeman
 
CONTINUE READING
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Gabriele Bazzocchi, M.D., PhD, A.G.A.F.
                            Neuro-Gastroenterology and G.I. Rehabilitation Unit
                               Montecatone Rehabilitation Institute
                                         Imola (Italy)

 Milano, 25 Novembre 2019

 IL TRATTAMENTO
 FARMACOLOGICO
DELLA DISMOTILITA’
 INTESTINALE NEL
 PAZIENTE CON SCI
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Intestinal evacuation is direct consequence of the
     propagating contractions (HAPC) action

Repeated HAPC associated with an urge to defecate and the defecation
            Bazzocchi G et al. Gastroenterology 1991; Herbst F et al. GUT 1997; 41: 381-389
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Propagating High Amplitude
                                     Contractions (HAPC) induce the
                                     principal ab-oral transport of the
                                       intraluminal colonic contents

         Rapid
  scintigraphic scans
     (1-min interval)
   showing transport
  from the right colon
into the rectum during
         HAPC
                         min   +67         +68                +69

                                            Bazzocchi G et al. Gastroenterology 1991
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Colorectal transport during defecation in subjects with supraconal spinal cord injury
                                        Rasmussen MM et al. Spinal Cord 2013; 51: 683- 7

                                Normal subject
          Before defecation                               After defecation
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
The Guinea-pig proximal
colon, colonic flexure, and
distal colon, removed from
freshly killed animal and
showing the normal
appearance of fecal
contents

Costa M et al.
Neurogastroenterol Motil 2015
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
THE ENTERIC NERVOUS SYSTEM: THE SECOND BRAIN

                                               ~ 50 transmitters / modulators / messengers
                                                 (i.e. amines, neuropeptides, gases, etc…)

                                                                          ~ 20 subclasses of functionally distinct neurons
                                                                                 (i.e. IPANS, interneurons, motorneurons, etc…)

                                                                              various integrated reflex pathways
                                                                               (i.e. Peristalsis, MMC, secretomotor reflexes, etc…)

                                                    neuroplasticity
                                           (i.e. maintenance and repair)

                                                                               De Giorgio R., et al., TiPS, 2007; 28:473-81

 submucous
   plexus                                  as a third and distinct division of the
                              myenteric   Autonomic Nervous System along with
5x   108   neurons (humans)    plexus     the sympathetic and parasympathetic
                                                         divisions

                                           Camilleri M et al. Nature Reviews 2017
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
MECHANISMS UNDERLYING COLONIC MOTOR PATTERNS

Spencer NJ et al. J Physiol 2016; 594: 4099-4116

                                                    Mechanosensory enteric neurons
                                                     have essential mechanosensitive
                                                     nerve endings in the circular
                                                     muscle.
                                                    Distension or stretch of the colon
                                                     activates these sensory neurons to
                                                     initiate polarized neural pathways
                                                     that result in oral contraction and
                                                     anal relaxation.
                                                    These pathways do not require the
                                                     mucosa but can be modulated by
                                                     sensory nerve endings that project
                                                     into the mucosa.
                                                    The polarized enteric circuits form
                                                     the bases of a neuromechanical
                                                     loop which ensures that polarized
                                                     enteric neural circuitry can
                                                     efficiently propel content with a
                                                     wide range of physical properties.
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
NEUROMECHANICAL FACTORS INVOLVED IN
THE
FORMATION AND PROPULSION OF FECAL
PELLETS IN THE GUINEA-PIG.
                                               PROPULSION IS NOT A SIMPLE
Costa M et al. Neurogastroenterol Motil 2015   REFLEX BUT RATHER A MORE
                                               COMPLEX PROCESS INVOLVING AN
                                               ADAPTABLE NEUROMECHANICAL
                                               LOOP

                                               ……..BOLUS SIZE AND
                                               CONSISTENCY AFFECTS
                                               PROPULSION SPEED…
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Distension of the descending colon induces increase in rectal tone in
                             pts with SCI
IL TRATTAMENTO FARMACOLOGICO DELLA DISMOTILITA' INTESTINALE NEL PAZIENTE CON SCI - GABRIELE BAZZOCCHI, M.D., PHD, A.G.A.F. MONTECATONE ...
Factors associated with successful decrease and discontinuation of
       Antegrade Continence Enemas (ACE) in children with defecation disorders:
                a study evaluating the effect of ACE on colonic motility

Colon motility tracing demonstrating
improvement of HAPCs:
(A): Normalization of HAPCs from partial to
full propagation
(B): Normalization of HAPCs from absent to full propagation
                                                    Liem O et al. Neurogastroenterol Motil 2010
COLONIC MOTILITY DURING RECTOCLYSIS

          irrigation
PATIENTS
                                               16 SCI pts, 10 tetraplegic,
                                               ASIA A post-traumatic lesion
                            50 cms

                          40 cms
              20 cms                   Intraluminal pressure recording points

        10 cms

                             30 cms

Internal Anal Sphincter
                            30 min later manometric probe was placed into the
                            colonic lumen, a Trans Anal Irrigation procedure using
                            Peristeen® device was performed according to the
                            following protocol:

                                                    Bazzocchi G et al. Pelviperineology 2012; 31: 85-92
LEFT COLON MANOMETRY during TRANS ANAL IRRIGATION
                      50 cm

                      40 cm

                      30 cm

                      20 cm

                      10 cm

                       SAI

                 Catheter balloon

Irrigation
initiation                water

                                           Bazzocchi G et al. Pelviperineology 2012; 31: 85-92
Abdominal x-ray film in a   Abdominal x-ray film in the
pts with SCI after 6 days   previous patient (CF) after
 where 10 radioopaque               only one
markers were taken daily.    TRANS ANAL IRRIGATION
                                     session
 Patient (CF) had only 1
                              by means of Peristeen
bowel movement during
      study week
Transanal irrigation
          Before irrigation                                After irrigation

Anterior view of the 111In-labeled bowel content before washout (A) and after (B):
the colon is empty anal to the left colic flexure
                                    Christensen P et al. Dis Colon Rectum 2003: 46:68-76
 Laboratory animals are tetrapedal

                                                       They do not stop normal activity to defecate

                                                       They do not adopt a defecatory posture

 Humans normally retain feces and defecate only
  intermittently

 Differences in the structure and functional
  characteristics of the pelvic floor of humans compared
  with tetrapods reflect its important role in continence
  imposed by an upright posture
Constipation
                        Pelvic Floor Musculature
                   At rest                    Straining to defecate

Symphysis
  pubis

                                     Coccyx

                             Anorectal
                              angle                             Anorectal
    Puborectalis                                                 angle
                                Rectum
            External
              anal
            sphincter                                    Descent of
                                                         pelvic floor
The nerve pathways for voluntary control
      of defecation and fecal continence

                                                          GUT innervation by ANS ce

BN: Barrington’s nucleus;
LCG: Lateral Cell Group;
IML: InterMedioLateral column;
ENS: Enteric Nervous System;
Pelv gang: pelvic ganglia; 2 ord: second order neurons;
ON: Onuf’s nucleus
NORMAL COLONIC MOTILITY      NORMAL ANORECTAL
                                SENSATION

                NORMAL DEFECATION

                                 NORMAL RECTAL
                                EXPULSION FORCE
NORMAL ANORECTAL
NORMAL COLONIC MOTILITY          SENSATION

                 NORMAL DEFECATION

     COORDINATED
                                  NORMAL RECTAL
   ABDOMINAL- PELVIC
                                 EXPULSION FORCE
      and PERINEAL
    NEUROMUSCOLAR
      FUNCTION TO
        EVACUATE
NORMAL COLONIC MOTILITY                    NORMAL ANORECTAL
                                              SENSATION

              NORMAL DEFECATION

  COORDINATED
                                               NORMAL RECTAL
ABDOMINAL- PELVIC
                                              EXPULSION FORCE
   and PERINEAL
 NEUROMUSCOLAR
   FUNCTION TO
     EVACUATE           NORMAL
                    Colonic intraluminal
                         content:
GUT MICROBIOTA: THE MOST
                                        DENSE AND COMPLEX
                                     BACTERIAL ECOSYSTEM ON
                                         THE PLANET EARTH
                                                     Bengmark S. Gut 1998
                                                     Sender R et al. PLoS Biol 2916

                                     BACTERIA ARE THE MAJOR COMPONENT
          200 billions/g →                    OF FORMED STOOL
     contributing of 0.5-1.0 kg
of the average adult’s body weight
CONSTIPATION CAN BE THE
     CONSEQUENCE OF
   DISTURBANCE OF THE
  MICROBIOTA BALANCE

Quigley EMM. The enteric microbiota in the
pathogenesis and management of
constipation. Best Practice &Research
Clinical Gastroenterology 2011

Rhee SH et al. Principles and clinical
implications of the
Brain-Gut-Enteric Microbiota Axis.
Nature Reviews Gastroenterology &
Hepatology 2009

Quigley EMM et al. Constipation and the
microbioma: lumen versus mucosa.
Gastroenterology 2016; 150: 300-303

“AN EMPY COLON HAS
NO MOTOR ACTIVITY”
Costa M et al.
Am J Physiol Gastrointest Liver Physiol 2013
IN PTS WITH SLOW TRANSIT CONSTIPATION HAPC OCCURRENCE IS
SIGNIFICANTLY REDUCED AFTER MEAL (M) AND DURING AWAKENING (A)

                         Bazzocchi G et al. Gastroenterology 1991; 98: 686-93
                       Bassotti G et al. World J Gastroenterol 2005; 11: 2691-6.
Neurogastroentero
Motil 2011
 There were no HAPC observed in the SCI group during pre-sleep, sleep, and post-sleep phases.

 All non-SCI subjects experienced subjective symptoms (e.g. sensation of flatus) and
  two had bowel movements in close proximity to having HAPC in the post-sleep phase.
Abdominal X-RAY in ♀ with p.t. paraplegia
Scintigraphic study showing defecation produces a complete emptying of the
                 left colon in normal subjects, but not in SCI
                        Before defecation        After defecation

           Normal
 (Score = 81 (53-140)

              SCI
   (Score = 27 (0-44)

                                            Rasmussen MM et al. Spinal Cord 2013; 51: 683- 7
COLONIC TRANSIT STUDY WITH RADIOPAQUE MARKERS
                     IN A PATIENT WITH P.T. PARAPLEGIA
                                                            Patient reported daily bowel
                                                            movements during the 7 day study
                                                            period.
                                                            N° of markers ingested = 60

                                                            N° of markers in the large bowel on
                                                            the 7th day = 53

                                                            Total Transit Time = 127.2 hours
                                                            (n.v.
COLONIC TRANSIT in SCI:
 differentiate transport for
fluid and hard stool through
       the large bowel

  Radiopaque markers are
     not inserted in the
    formed/hard stools
Pathophysiology of Bowel Dysfunction in Spinal Cord Injury
There are intrinsic factors associated with the injury itself which disrupt normal motor and sensory
     functions within the g.i. tract. Additional external factors may influence bowel disorders.

                        Qi Z et al. Bowel management in Spinal Cord Injury. Curr Gastroenterol Rep 2018
BOWEL DYSFUNCTION in SCI
- GENERAL DECREASE IN MOTOR              DELAYED COLONIC
ACTIVITY IN THE COLONIC TRACTS             TRANSIT TIME
         (LACK OF HAPC?)

-    VISCERAL SENSORY LOSS
-    ABDOMINAL MUSCLE
                                                           INCOMPLETE
     INSUFFICIENCY                                         EVACUATION
                                       ANORECTAL
-    DEFECT IN THE STRIATED
                                         OUTLET
     MUSCLE CONTROL
-    RECTO-ANAL INHIBITORY            DYSFUNCTION
     REFLEX IS MAINTAINED

                                                     FORMATION OF POST-
                                                      EVACUATION FECAL
                              NOT SCHEDULED
                                                     RESIDUES AND THEIR
                               (UNWANTED)
                                                       ACCUMULATION
                               DEFECATION
        FECAL
    INCONTINENCE/
       SOILING                                  FECAL IMPACTION
                                                  IN THE LARGE
                                                      BOWEL
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence

                       Qi Z et al. Bowel management in Spinal Cord Injury. Curr Gastroenterol Rep 2018
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence

                                                                              Antispasmodics
                                                                              Antimeteorics
                                                                              Prebiotics
                                                                              Probiotics
                                                                              Synbiotics
                                                                              Antibiotics
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence

                                                                             loperamide?
                                                                             anal plugs?

                                                                             Cholestyramine

                                                                              Antispasmodics
                                                                              Antimeteorics
                                                                              Prebiotics
                                                                              Probiotics
                                                                              Synbiotics
                                                                              Antibiotics
FECAL RETENTION / COPROSTASIS / CONSTIPATION

                                              Colonic hypo-dysmotility

           DISORDERS of PERISTALSIS
                                                       Decrease of HAPC
 Diseases of the Enteric Nervous System               Disorders of retrograde
                                                        propulsion
 Changes in regulation by external signals            Alterations in regional
                                                        wall tone
 Reduced fecal volume and changes in stool
  consistency
FECAL RETENTION / COPROSTASIS / CONSTIPATION

                Colonic hypo-dysmotility
           MEDICAL and REHABILITATION APPROACH

          -   Poliethylene glycol (macrogol)
          -   Stimulant laxatives: sodium picosulphate, bisacodyl, sennosides
          -   Prokinetic drugs: prucalopride, linaclotide, neostigmine, trimebutine
          -   Water consumption (!??)
          -   Dietary (hydrosoluble) fiber supplementation
          -   Prebiotics
          -   Probiotics, symbiotics
          -   Lactulose, lactilole

          - Digital rectal stimulation
          - Abdominal massage
          - Mechanical distention of the colonic wall: COLONIC IRRIGATION

                                SURGERY ?
Physical factors in the stimulation
      of colonic peristalsis

     Hardcastle JD, Mann CV. Gut 1970; 11: 41-46
Bisacodyl and High-Amplitude-Propagating Colonic Contractions
                         in Children

 Hamid SA, Di Lorenzo C, Reddy SN, Alex F, Hyman P . J Pediatr Gastroenterol Nutr 1998
POLYETHYLENE GLYCOL solution
MACROGOL 3350/electrolyte improves constipation in
Parkinson’s disease and multiple system atrophy
                          Eichhorn TE, Oertel WH. Mov Disord 2001; 16: 1176-7

Long term efficacy, safety, and tolerabilitity of low daily doses of
isosmotic polyethylene glycol electrolyte balanced solution
(PMF-100) in the treatment of functional chronic constipation.
               Corazziari E, Badiali D, Bazzocchi G et al. Gut 2000; 46:522-6.

Polyethylene glycol solution in subgroups of chronic
constipation patients: experience in obstructed defecation.
                    Bazzocchi G. Ital J Gastroenterol Hepatol 1999; 31: S257-9
PRODOTTI a base di PEG
NOME (AIC)    FORMULAZIONE                     INDICAZIONE

MOVICOL       20 buste (1 in 125 ml)           Stipsi cronica idiopatica
              PEG 3350 (13,125 g) + E (NaCl,   e secondaria; fecaloma
(Norgine)
              KCl, Ca2Na)

MOVICOL                                        Stipsi cronica idiopatica
SENZA AROMA   20 buste (1 in 125 ml)           e secondaria; fecaloma
(Norgine)     PEG 3350 (13,125 g) + E

MOVICOL
              Flacone da 500 ml                Stipsi cronica idiopatica
CONCENTRATO
              PEG 3350 (13,125 g) + E          e secondaria
(Norgine)

MOVICOL
SOLUZIONE     20 buste da 25 ml                Stipsi cronica idiopatica
ORALE                                          e secondaria; fecaloma
              PEG 3350 (13,125 g) + E
(Norgine)

MOVICOL       20 buste (1 in 62,5 ml)          Stipsi cronica nei
BAMBINI       PEG 3350 (6.9 g) + E             bambini da 2 a 11 anni.
                                               Fecaloma nei bambini
(Norgine)                                      sopra i 5 anni.

MOVICOL                                        Stipsi cronica nei
              20 buste (1 in 62,5 ml)          bambini da 2 a 11 anni.
BAMBINI
              PEG 3350 (6.9 g) + E             Fecaloma nei bambini
SENZA AROMA
                                               sopra i 5 anni.
(Norgine)
PRODOTTI a base di PEG
NOME (AIC)            FORMULAZIONE             INDICAZIONE

SELG 250              16 buste (1 in 250 ml)   Trattamento della
                                               stitichezza
(Alfa Wassermann)
                      PEG 4000 (14,8 g)        Bambini di peso superiore
                      + E + solfato di sodio   ai 20Kg

ISOCOLAN              8 buste (1 in 250 ml)    Trattamento della
                                               stitichezza
(Zambon)
                      PEG 4000 (17,4)
                      + E + solfato di sodio

COLIREI               16 buste (1 in 250 ml)   Pulizia dell’intestino prima
                                               di indagini diagnostiche o
Abc (in concessione                            interventi chirurgici sul
a Sofar)              PEG 4000 (14,8 g)
                                               colon-retto. Trattamento
                      + E + solfato di sodio   saltuario della stipsi
                                               funzionale.

PERGIDAL              20 buste (1 in 125 ml)   Trattamento della
                                               stitichezza
(Valeas)
                      PEG 4000 (7,3 g)
                      + E + solfato di sodio
PRODOTTI a base di PEG
NOME (AIC)    FORMULAZIONE                    INDICAZIONE

PAXABEL       20 BUSTE                        Trattamento
                                              sintomatico della
(Ipsen)                                       stipsi nell’adulto e nel
              PEG 4000 (10 g) (1 in 125 ml)
                                              bambino (6 mesi – 8
                                              anni)
              PEG 4000 (4 g) (1 in 50 ml)

LAXIPEG       Polvere barattolo 200g          Trattamento di breve
                                              durata della
(Zambon)                                      stitichezza
              20 buste 9,7 g
                                              occasionale
              PEG 4000

REGOLINT      Polvere barattolo 200 grammi    Trattamento della
                                              stitichezza nel
(Baldacci)                                    bambino
              20 buste da 9,7 grammi
                                              Trattamento di breve
                                              durata della
              PEG 4000                        stitichezza
                                              occasionale
CASENLAX      20 buste 10g                    Trattamento
                                              sintomatico della
(Recordati)                                   stipsi
              PEG 4000
ULTIMEa NOVITA’
                                      PRODOTTI   base di PEG
NOME (AIC)           FORMULAZIONE            INDICAZIONE

ONLIGOL              20 BUSTE 10g            Stitichezza cronica o
                                             intestino occasionalmente
(Alfawassermann)                             irregolare
                     Flacone polvere 400g

Dispositivo Medico   PEG 4000

SANIPEG              300g barattolo          Trattamento sintomatico
                     20buste 4g              della stipsi
Sanitas
                     20 buste 10

Dispositivo Medico   PEG (non specificato)

CLIN 4000            Barattolo 200g          Stitichezza cronica o
                     30buste 10g             intestino occasionalmente
Akkadeas                                     irregolare
                     PEG 4000
Dispositivo Medico

MACROGOL             20 buste 13,8g          Stitichezza cronica;
GENERICI                                     fecaloma
                     PEG 3350 + E

Mylan (Goganza)/
Sandoz/
Carlo Erba….
A safe and effective multi-day colonoscopy bowel preparation for
individuals with spinal cor injuries
Song SH et al. J Spinal Cord Med 2018
   Day 1:
   - Start clear liquid diet at dinner
   - Magnesium citrate 480 ml after dinner

   Day2:
   - Continue clear liquid diet
   - PEG 3350 and electrolyte colonic lavage solution (PEG-ELS) 4L over 2 hours in the
     morning

   Day 3:
   - Continue clear liquid diet until midnight, then nothing per os
   - PEG-ELS over 2 hours in the morning

   Day 4: - Is rectal/colostomy output clear?
                                        YES           NO

   READY FOR COLONOSCOPY
                                                  PEG-ELS 2L PRIOR COLONOSCOPY
 Colonic intraluminal contents have a sub-
  stantial effect on colonic transit

 In female controls bowel cleansing
  shortened rectosimoid transit

 Women with constipation had faster
  transit in the cleansed state, however,
  the distribution of markers was not altered:
  DELAYS in TRANSIT TIME were still
  present in the same colonic tract
PROKINETICS DRUGS
Neostigmine
Prucalopride
Linaclotide
Cisapride
Domperidone
Trimebutine
Levolsulpiride
Erythromycin
Misoprostol
Neostigmine reduced the time to first flatus, time to start of bowel movement,
time to end of bowel movement, and time for total bowel care as compared to placebo

INTRASTIGMINA f. 1 ml, 0.5 mg TID
PRUCALOPRIDE 2 mg significantly reduced total colonic transit time in patients
with supraconal SCI
This reduction in transit time was also associated with an increase in the weekly frequency

RESOLOR 2 mg cpr, 1 cpr 5 hours before scheduled evacuation
Effect of 5 days linaclotide on transit and bowel
                              function in females with constipation-
                              predominant Irritable Bowel Syndrome.
                              Andresen V. et al. Gastroenterology 2007; 133: 761-8

CONSTELLA 290 mg, caps, 30 min before breakfast or lunch
PROKINETICS DRUGS
Neostigmine
Prucalopride
Linaclotide
Cisapride
Domperidone
Trimebutine
Levolsulpiride
Erythromycin
Misoprostol
- Intravenous administration of 100 mg trimebutine was followed,
Poynard T. et al.                                  TRIMEBUTINE and IBS
META-ANALYSIS OF SMOOTH MUSCLE RELAXANTS IN THE
TREATMENT OF IBS
-1888 pts, 23 randomized clinical trials
- global assessment, pain, abdominal distension, constipation improved
  significantly with cimetropium, mebeverine, otilonium, pinaverium and trimebutine

                                                                APT 2001; 15: 355-61
Rahman MZ et al.
COMPARATIVE EFFICACY AND SAFETY OF TRIMEBUTINE
VERSUS MEBEVERINE IN THE TREATMENT OF IRRITABLE
BOWEL SYNDROME
-IBS-QOL was assessed in 122 pts with IBS before and after 6 weeks of treatment
with trimebutine 100 mg b.i.d. or mebeverine 135 mg b.i.d.

- QOL score decreased from 103 to 82 in trimebutine and from 106 to 95 in
  mebeverine group: improvement in both groups was statistically significant, as the
difference between the two groups.
                                              Mymensingh Med J 2014; 23: 105-13
LEVOSULPIRIDE IN IBS
    Lanfranchi GA, Bazzocchi G, Marzio L et al.
    INHIBITION OF POSTPRANDIAL COLONIC MOTILITY BY SULPIRIDE IN
    PATIENTS WITH IRRITABLE COLON

- administration of sulpiride 100 mg i.m. significantly reduced the postprandial increase in colonic motor
  activity
- dopaminergic receptors may be involved in the colonic motor response to food

                                                                  Eur J Clin Pharmacol 1983; 769: 772
LEVOSULPIRIDE IN IBS

- Levosulpiride 25 mg t.i.d. for 10 days
  accelerate colonic transit time more than
  placebo in 20 pts with Functional
  Constipation or IBS
- Levosulpiride was better than domperidone in improving 6 out
                          of 10 recorded symptoms, and was better than metoclopramide
                          in improving 6 out of 10 selected symptoms
                                   anorexia
                                   nausea
                                   vomiting
                                   upper abdominal pain
                                   postprandial bloating
                                   abdominal fullness
                                   early satiety
                                   belching
                                   heartburn
                                   regurgitation

LEVOSULPIRIDE 25 mg 30 min before meals
Advantages of Azithromycin Over Erythromycin in Improving the
Gastric Emptying Half-Time in Adult Patients With Gastroparesis

Jean M Larson et al.
J NEUROGASTROENTEROL MOTIL 2010; 16: 407-413

              Erythromycin 250 mg f, 1 f i.v. TID
              ERITROCINA 200 mg cpr masticabili
              ERITROCINA 10% granulato sosp orale
CYTOTEC 200 µg, 2 cpr TID
QUESTRAN 4 gr polvere x sosp orale, 1 busta ad ogni pasto
Management of neurogenic bowel dysfunction manifesting as constipation and fecal incontinence

                                                                             loperamide?
                                                                             anal plugs?

                                                                             Cholestyramine

                                                                              Antispasmodics
                                                                              Antimeteorics
                                                                              Prebiotics
                                                                              Probiotics
                                                                              Synbiotics
                                                                              Antibiotics
Primary endpoints:
-    bowel evacuations with normal stool consistency
-    Intestinal Transit Time

Secondary endpoints:
-    Symptoms according to Rome III Diagnostic Criteria
-    Agachan-Wexner score
-   Changes in gut microbiota composition
abdominal bloating
                    No effect on pain, gas, urgency

 flatulence
 colonic transit

                      Mean BSFS scores and
                      CSBMs/week increased in
                      FC
GUT DYSBIOSIS IMPAIRS RECOVERY AFTER SPINAL CORD INJURY

                                                                               In mice with experimental SCI,
                                                                               the pre-existence of intestinal
                                                                               dysbiosis caused larger lesions
                                                                               to form after injury.
                                                                                  Kigerl KA et al. J Experim Med 2016;
                                                                                                           213: 2603-20

Probiotics (VSL#3) confer neuroprotection and improve locomotor recovery after SCI
In an effort to develop a clinically feasible therapeutic protocol, SCI mice received VSL#3 probiotics starting immediately
after injury and then again daily until 35 dpi. In VSL#3-treated SCI mice, locomotor recovery was significantly improved
relative to vehicle-treated SCI mice. VSL#3 increased the frequency of plantar stepping and fore limb–hind limb
coordination with concomitant improvements in paw position and trunk. VSL#3 also reduced lesion volume and
axon/myelin pathology at the injury epicenter. Smaller lesion volumes in the VSL#3-treated mice correlated with
improved behavioral recovery.
Alpha diversity (i.e. biodiversity) of the GUT MICROBIOTA from 100 pts with
SCI and 100 healthy subjects matched for age and sex.
A stool sample was collected during the first week after admission to 10 Spinal Units scattered all
over the Italian territory

                                    p=0.001 ***
Diversity of the GUT MICROBIOTA structure
Diversity of the GUT MICROBIOTA          between pts showing greater severity of
STRUCTURE between pts with AIS score A   the SCI (cervical or thoracic lesional level
or B vs pts with AIS score C or D        with AIS score A or B) vs pts with minor
                                         severity (AIS score C or D or lumbar level)
                     p=0.029*

                                                                p=0.036 *
Fecal microbiota
transplantation in spinal
cord injury.
Brechmann T et al. WJG 2015

Amount of fresh feces prepared for
infusion or infused fecal suspension:
from 30 to 250 g of fresh stool in 30 to
700 mL. Number of FMT regimens: from
single treatments to 14
TAKE HOME MESSAGE
 Gli studi che valutano efficacy/safety di farmaci potenzialmente utili nel
   trattamento dei disturbi intestinali dopo mielolesione sono ancora troppo
   pochi
 L’evidenza di un overlap tra la disfunzione intestinale nella persona con
  patologie del SNC e quella della popolazione con disturbi «funzionali»
  autorizza all’impiego di numerosi farmaci per ben specificati obiettivi
  terapeutici
 Per le specificità, in termini di complessità dei problemi e tempi, del
  trattamento medico/riabilitativo di cui necessita una persona con SCI, i
  Prontuari Ospedalieri di cui siamo dotati non sono adeguati
 La cura della disfunzione intestinale dopo SCI mostra di essere cruciale ai
  fini della morbidità e QoL di questi pazienti
You can also read